- Home
- GDTC vs AEON Comparison
GDTC vs AEON Comparison
Compare GDTC & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDTC | AEON |
|---|---|---|
| Founded | 2018 | N/A |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5M | 13.2M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | GDTC | AEON |
|---|---|---|
| Price | $0.94 | $1.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.20 |
| AVG Volume (30 Days) | 38.4K | ★ 188.7K |
| Earning Date | 04-24-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $573,193.00 | N/A |
| Revenue This Year | $5.37 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 63.03 | N/A |
| 52 Week Low | $0.89 | $0.38 |
| 52 Week High | $3.68 | $16.06 |
Technical Indicators
Market Signals| Indicator | GDTC | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 20.48 | 58.00 |
| Support Level | $0.89 | $1.02 |
| Resistance Level | $1.39 | $1.18 |
| Average True Range (ATR) | 0.13 | 0.10 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 7.13 | 50.08 |
Price Performance
Historical ComparisonAbout GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.